Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition: Coronary Artery Disease Interventions: Drug: Ticagrelor; Drug: Prasugrel Sponsors: Germano Di Sciascio; Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy; CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK; Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials
